Form 4: LeMaitre Vascular Director Exercises Stock Options

Sentiment:

Insider Transaction Report 21 November 2025 5:55 PM

LeMaitre Vascular Director John O'Connor exercised options to acquire 7,500 shares of common stock, increasing his direct beneficial ownership.

Summary

John O'Connor, a Director of LeMaitre Vascular, Inc. (LMAT), acquired 7,500 shares of common stock through the exercise of stock options.
The transaction occurred on November 21, 2025, at an exercise price of $37.29 per share.
Following this transaction, O'Connor directly beneficially owns 64,801 shares of LeMaitre Vascular common stock.
The exercised option was fully vested and exercisable as of December 2, 2020, and had an expiration date of December 2, 2025.
A Limited Power of Attorney was executed on November 14, 2025, appointing Laurie Churchill, John Pitfield, Bernard Stanford, and Secil Kantarci ONeil as attorneys-in-fact to execute and file SEC forms on behalf of John O'Connor.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to a director increasing their direct ownership, even if through a routine option exercise. It indicates continued alignment of interests with shareholders.

Positives

Director John O'Connor increased his direct beneficial ownership in LeMaitre Vascular by 7,500 shares, which can be viewed as a positive signal of confidence in the company.
The option was exercised at a price of $37.29, indicating the option was in-the-money at the time of exercise.

Future Outlook

Industry Context

This filing reports a routine insider transaction (option exercise) and does not provide information related to broader industry trends or competitors.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Establishment of Authority	John O'Connor executed a Limited Power of Attorney, granting specific individuals the authority to prepare, execute, and file SEC forms (including Forms 3, 4, 5, 13D, and 13G) on his behalf as an officer and/or director of LeMaitre Vascular, Inc.	11/14/2025	This streamlines the process for SEC compliance filings for the director, ensuring timely and accurate reporting of beneficial ownership changes.

Related Party Transactions

The exercise of stock options by a director is a standard form of compensation and an insider transaction.

Stakeholder Impact

Shareholders: The increase in direct ownership by a director may be viewed as a positive signal of management's continued commitment and belief in the company's future prospects.
Employees: No direct impact mentioned.

Key Dates

Date	Description
12/02/2020	Date when the stock option became fully vested and exercisable.
11/14/2025	Date of execution of the Limited Power of Attorney by John O'Connor.
11/21/2025	Date of the option exercise transaction and the filing of the Form 4.
12/02/2025	Expiration date of the stock option.

Recommendation

hold

The filing details a routine insider transaction (option exercise) by a director. While it increases the director's stake, it does not present new information or significant strategic shifts that would warrant a change in investment recommendation. Such transactions are generally expected and do not typically have a material impact on the company's valuation or future prospects.

Keywords

LeMaitre Vascular, LMAT, Insider Transaction, Form 4, Stock Option Exercise, Director Ownership, Beneficial Ownership, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.